Ignite Creation Date:
2024-05-05 @ 9:27 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00890162
Status:
COMPLETED
Last Update Posted:
2019-07-01
First Post:
2009-04-28
Brief Title:
A Randomized Double-Blind Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Sponsor:
Organization:
National Institutes of Health Clinical Center CC